Neurocrine Bioscience buy Wells Fargo & Company
Start price
13.02.26
/
50%
€105.55
Target price
13.02.27
€147.44
Performance (%)
-0.95%
Price
13.02.26
€104.55
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by -0.95%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -0.95% |
| iShares Core DAX® | 1.927% |
| iShares Nasdaq 100 | -0.184% |
| iShares Nikkei 225® | 7.076% |
| iShares S&P 500 | -0.201% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Wells Fargo & Company from $180.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat